Join Growin Stock Community!

Turn therapeutics inc.TTRX.US Overview

US StockHealthcare
(No presentation for TTRX)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

TTRX AI Insights

TTRX Overall Performance

TTRX AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

TTRX Recent Performance

-2.43%

Turn therapeutics inc.

0.05%

Avg of Sector

-0.31%

S&P500

TTRX PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

TTRX Key Information

TTRX Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

TTRX Profile

Price of TTRX

TTRX FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

TTRX Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.11
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
223.17
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.11
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
223.17
Price-to-FCF
-
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%

  • When is TTRX's latest earnings report released?

    The most recent financial report for Turn therapeutics inc. (TTRX) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating TTRX's short-term business performance and financial health. For the latest updates on TTRX's earnings releases, visit this page regularly.

  • How much debt does TTRX have?

    As of the end of the reporting period, Turn therapeutics inc. (TTRX) had total debt of 91.17K, with a debt ratio of 0.02. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does TTRX have?

    At the end of the period, Turn therapeutics inc. (TTRX) held Total Cash and Cash Equivalents of 3.11M, accounting for 0.72 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.